Scalper1 News
Gene-sequencing company Illumina late Monday reported blowout third-quarter earnings and sales growth, and raised its full-year guidance, sending the stock up 10% in after-hours trading. Earnings, excluding one-time items, rose 71% vs. a year earlier to 77 cents a share, topping the analyst consensus by 21 cents, according to Thomson Reuters. Sales rose 35% to $481 million, the best year-over-year gain in more than three years and Scalper1 News
Scalper1 News